COMP <GO>
AVTR vs JNJ // FORWARD P/E MULTIPLE
Avantor Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: AVTR 2
— JNJ 11
▲ FORWARD P/E MULTIPLE LEADER: JNJ
LAST: $16.05 (-3.78%) • MKT CAP: $11.30B
forward-pe
31.0x
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
forward-pe
23.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVTR VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVTR | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.70% | 67.90% | -35.20 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.10% | 25.50% | -27.60 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.38% | 2.97% | +1.41 | AVTR | /fcf-yield <GO> |
| Operating Margin | -3.80% | 34.70% | -38.50 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -8.10% | 28.50% | -36.60 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | -3.40% | 6.00% | -9.40 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.88 | 5.59 | -3.71 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 7.20% | -0.30 | AVTR | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.1 | 60.4 | -11.25 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 1.08 | -0.07 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 31.0x | 23.0x | +8.00 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.30B | $662.49B | -$651.19B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVTR REV | JNJ REV | AVTR GROSS % | JNJ GROSS % | AVTR FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.55B | $94.19B | 32.7% | 67.9% | $495.0M | $19.70B |
| FY 2024 | $6.78B | $88.82B | 33.6% | 69.1% | $692.0M | $19.84B |
| FY 2023 | $6.97B | $85.16B | 44.0% | 44.0% | $556.5M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVTR // BETA 1.01
JNJ // BETA 1.08